Kornitzer Capital Management Inc. KS boosted its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 3.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 109,690 shares of the company's stock after buying an additional 3,145 shares during the quarter. Kornitzer Capital Management Inc. KS's holdings in Colgate-Palmolive were worth $9,972,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of CL. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at $32,000. Hager Investment Management Services LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at $36,000. Reston Wealth Management LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at $42,000. Roxbury Financial LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at $43,000. Finally, Synergy Asset Management LLC purchased a new stake in Colgate-Palmolive in the 4th quarter worth about $49,000. Institutional investors own 80.41% of the company's stock.
Wall Street Analyst Weigh In
CL has been the subject of several research analyst reports. Stifel Nicolaus reduced their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a research note on Monday, February 3rd. UBS Group lowered their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a report on Monday, February 3rd. Morgan Stanley lowered their target price on Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a report on Monday, February 3rd. Piper Sandler decreased their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a report on Monday, January 6th. Finally, JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating for the company in a research report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $101.16.
Check Out Our Latest Research Report on CL
Colgate-Palmolive Price Performance
Shares of CL traded up $1.69 during midday trading on Friday, hitting $89.56. The company's stock had a trading volume of 4,747,229 shares, compared to its average volume of 4,884,892. Colgate-Palmolive has a one year low of $84.45 and a one year high of $109.30. The company's fifty day simple moving average is $89.02 and its two-hundred day simple moving average is $95.99. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The stock has a market capitalization of $72.68 billion, a price-to-earnings ratio of 25.44, a price-to-earnings-growth ratio of 4.18 and a beta of 0.44.
Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the business posted $0.87 EPS. As a group, equities analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.23%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio is 56.82%.
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.